Dopamine receptors and schizophrenia.
Reynolds
G P
GP
Department of Biomedical Science, University of Sheffield, U.K.
D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001921:Brain / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D011954:Receptors, Dopamine / Q000502:physiology*; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D050638:Receptors, Dopamine D4; D012559:Schizophrenia / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology*
D014150:Antipsychotic Agents; C493599:DRD4 protein, human; D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2; D050638:Receptors, Dopamine D4